Parkin is transcriptionally regulated by ATF4: Evidence for an interconnection between mitochondrial stress and ER stress

Cell Death and Differentiation

Volumn 18, Issue 5, 2011, Pages 769-782

  Bouman, L ^a   Schlierf, A ^a   Lutz, A K ^a   Shan, J ^b   Deinlein, A ^a   Kast, J ^a   Galehdar, Z ^c   Palmisano, V ^a   Patenge, N ^d   Berg, D ^d   Gasser, T ^d   Augustin, R ^e   Trumbach D ^e   Irrcher, I ^c   Park, D S ^c,f   Wurst, W ^e,g   Kilberg, M S ^b   Tatzelt, J ^a   Winklhofer, K F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Pusan National University   (South Korea)

^g MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

ATF4; c Jun; ER stress; parkin; Parkinson's disease; UPR

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; MESSENGER RNA; PARKIN; PROTEASOME; PROTEIN C JUN;

ANIMAL CELL; ARTICLE; CELL ORGANELLE; CELL PROTECTION; CELL SURVIVAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; MITOCHONDRION; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REPRESSOR GENE; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

EID: 79954417075     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.142     Document Type: Article

References (40)

1. Winklhofer KF, Haass C. Mitochondrial dysfunction in Parkinson0s disease. Biochimica Et Biophysica Acta 2010; 1802: 29-44.
2. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 2008; 7: 97-109. (Pubitemid 350251942)
3. Wang HQ, Takahashi R. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid Redox Signal 2007; 9: 553-561. (Pubitemid 46598253)
4. Lindholm D, Wootz H, Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ 2006; 13: 385-392.
5. Ghribi O, Herman MM, Pramoonjago P, Savory J. MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-kappaB signaling pathways. J Neuropathol Exp Neurol 2003; 62: 1144-1153. (Pubitemid 37413825)
6. Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J Neurosci 2002; 22: 10690-10698. (Pubitemid 36005143)
7. Holtz WA, O'Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 2003; 278: 19367-19377. (Pubitemid 36799332)
8. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B et al. Alpha-synuclein blocks ER-golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 2006; 313: 324-328. (Pubitemid 44480951)
9. Smith WW, Jiang H, Pei Z, Tanaka Y, Morita H, Sawa A et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet 2005; 14: 3801-3811. (Pubitemid 43020082)
10. Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W. Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun 2007; 354: 707-711. (Pubitemid 46186242)
11. Moran LB, Croisier E, Duke DC, Kalaitzakis ME, Roncaroli F, Deprez M et al. Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra. Acta Neuropathol (Berl) 2007; 113: 253-263. (Pubitemid 46443561)
12. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin. Cell 2001; 105: 891-902. (Pubitemid 32635090)
13. Imai Y, Soda M, Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem 2000; 275: 35661-35664.
14. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al. Mutations in the parkin gene cause autosomal parkinsonism. Nature 1998; 392: 605-608. (Pubitemid 28207717)
15. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8: 519-529. (Pubitemid 46985379)
16. Kim I, XuW, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008; 7: 1013-1030.
17. Pizzo P, Pozzan T. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. Trends Cell Biol 2007; 17: 511-517. (Pubitemid 47562768)
18. Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E et al. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J Neurosci 2007; 27: 1868-1878.
19. Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008; 183: 795-803.
20. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362-367. (Pubitemid 28295292)
21. Marchand A, Tomkiewicz C, Magne L, Barouki R, Garlatti M. Endoplasmic reticulum stress induction of insulin-like growth factor-binding protein-1 involves ATF4. J Biol Chem 2006; 281: 19124-19133. (Pubitemid 44035417)
22. Steinmuller L, Thiel G. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2). Biol Chem 2003; 384: 667-672. (Pubitemid 36609182)
23. Masuoka HC, Townes TM. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood 2002; 99: 736-745. (Pubitemid 34525531)
24. Waetzig V, Herdegen T. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol Sci 2005; 26: 455-461. (Pubitemid 41207877)
25. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 2003; 12: 2277-2291. (Pubitemid 37160872)
26. Lutz AK, Exner N, Fett ME, Schlehe JS, Kloos K, Lammermann K et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 2009; 284: 22938-22951.
27. Sandebring A, Thomas KJ, Beilina A, van der Brug M, Cleland MM, Ahmad R et al. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS one 2009; 4: e5701.
28. Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson0s disease. Proc Natl Acad Sci USA 2004; 101: 665-670. (Pubitemid 38084694)
29. Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G et al. Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 2005; 21: 363-377. (Pubitemid 40204240)
30. Hasegawa T, Treis A, Patenge N, Fiesel FC, Springer W, Kahle PJ. Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways. J Neurochem 2008; 105: 1700-1715. (Pubitemid 351678502)
31. Cha GH, Kim S, Park J, Lee E, Kim M, Lee SB et al. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc Natl Acad Sci USA 2005; 102: 10345-10350. (Pubitemid 41023373)
32. Hom JR, Gewandter JS, Michael L, Sheu SS, Yoon Y. Thapsigargin induces biphasic fragmentation of mitochondria through calcium-mediated mitochondrial fission and apoptosis. J Cell Physiol 2007; 212: 498-508. (Pubitemid 47025640)
33. Tanabe M, Izumi H, Ise T, Higuchi S, Yamori T, Yasumoto K et al. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines. Cancer Res 2003; 63: 8592-8595. (Pubitemid 38064031)
34. Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999; 397: 271-274. (Pubitemid 29051178)
35. Krappmann D, Wulczyn FG, Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J 1996; 15: 6716-6726. (Pubitemid 26413803)
36. Waetzig V, Herdegen T. A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell death. J Biol Chem 2003; 278: 567-572. (Pubitemid 36043610)
37. Rambold AS, Miesbauer M, Rapaport D, Bartke T, Baier M, Winklhofer KF et al. Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol Biol Cell 2006; 17: 3356-3368. (Pubitemid 44156431)
38. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, Slack RS et al. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J Neurosci 2004; 24: 2963-2973. (Pubitemid 38405744)
39. Chen H, Pan YX, Dudenhausen EE, Kilberg MS. Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation. J Biol Chem 2004; 279: 50829-50839. (Pubitemid 40017821)
40. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005; 21: 2933-2942. (Pubitemid 40916416)